These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 12377838)

  • 1. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
    Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
    Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
    Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
    Fisher AJ; Wardle J; Dark JH; Corris PA
    J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
    Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant Recipients.
    Rosenberger EM; DiMartini AF; DeVito Dabbs AJ; Bermudez CA; Pilewski JM; Toyoda Y; Dew MA
    Transplantation; 2016 Jan; 100(1):239-47. PubMed ID: 26177087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
    Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
    J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
    Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
    Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.
    Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S
    J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.